{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Others > 2,5-Furandicarboxylic acidCAS：3238-40-2
Molecular Formula：C6H4O5
Molecular Weight：156.09
Storage：Powder:2-8℃，2 years
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 3238-40-2 |
| Name | 2,5-Furandicarboxylic acid |
| Molecular Formula | C6H4O5 |
| Molecular Weight | 156.09 |
| Solubility | Soluble in DMSO ≥0.1mg/mL(Need ultrasonic or Water bath) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years |
| EC | EINECS 221-800-8 |
| MDL | MFCD00016582 |
| Target Point | Others |
| Passage | Others |
| Background | It is a normal metabolite of human urine. |
| Unit | Bottle |
| Specification | 500mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response
Click to check >>Author：Yan Jia, Deng Xiu ling, Ma Shi qi, hui Li Yu, Gao Yu min, Shi Gui tao, Wang Hai sheng
IF：2.8380
Publish_to：BMC Complementary Medicine and Therapies
PMID：37202806
Manual Download
